創傷護理生物製劑市場：按產品類型、傷口類型、最終用戶和地區分類

Wound Care Biologics Market, By Product Type, By Wound Type, By End User, By Geography

出版日期: 2026年05月22日 | 出版商:

Coherent Market Insights | 英文 254 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

2026年創傷護理生物製劑市場規模估計為23億美元，預計2033年將達37億美元。預計2026年至2033年，該市場將以7.1%的複合年成長率成長。

報告範圍		報告詳情
基準年：	2025	2026年市場規模：	23億美元
歷史數據時期：	2020年至2024年	預測期：	2026年至2033年
2026年至2033年預測期間的複合年成長率：	7.10%	2033年市場規模預測：	37億美元

生物創傷護理產品利用活性生物製藥，例如動物和植物來源的活性生物分子，促進身體本身的修復機制，並具有抗氧化、抗菌或抗發炎作用。生物傷口敷料因其能提供濕潤的癒合環境、促進熱量、蛋白質和電解質的排出以加速癒合，並防止細菌污染，而被擴大用於術後和嚴重創傷病例。生物皮膚創傷護理產品包括組織工程產品。這些產品旨在暫時或永久取代受損皮膚。皮膚替代產品常用於傷口管理，並應用於治療各種疾病，例如壓瘡、糖尿病神經病變和血管功能不全性潰瘍。

市場動態

糖尿病盛行率上升、外科手術增多、創傷病例增加導致慢性潰瘍發生率上升，是創傷護理生物製劑市場成長的主要促進因素。根據世界衛生組織 (WHO) 2014 年的一項調查，交通事故、溺水、中毒、跌倒或燒燙傷造成的傷害佔全球死亡人數的 9%。 2013 年發表在《英國醫學雜誌》(BMJ) 旗下日誌《傷害預防》(Injury Prevention) 上的一項研究估計，有 9.73 億人遭受過需要某種形式醫療救治的傷害，其中 480 萬人死於傷害。該期刊還指出，交通事故 (29.1%)、自殘 (17.6%)、跌倒 (11.6%) 和人身暴力 (8.5%) 是造成傷害的主要原因。製造商也正致力於進行廣泛的研發工作，以開發新產品並擴展產品系列。例如，2016年，Integra Life Sciences Holdings公司的Integra真皮再生模板（IDRT）獲得FDA核准，用於治療糖尿病足潰瘍。本產品以Integra Omnigraft真皮再生基質的名稱進行銷售。此外，大眾對生物製藥的認知度不斷提高也促進了市場成長。這是因為越來越多的人選擇先進的醫療照護來預防傷口，以最大限度地減少慢性傷口的發生。然而，生物製藥的高昂成本以及創新組織工程產品上市的嚴格監管核准流程，阻礙了創傷護理生物製藥市場的成長。

本次調查的主要特點

本研究確定了各個細分市場的潛在商機，並說明了該市場具有吸引力的投資提案矩陣。
此外，本研究還提供了有關市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域展望以及主要參與者採取的競爭策略的重要見解。
本研究根據以下參數對全球創傷護理生物製劑市場的主要參與者進行了分析：公司概況、財務業績、產品系列、市場地位、分銷策略、關鍵發展和策略以及未來計劃。
透過利用本報告中的見解，企業負責人和經營團隊將能夠就未來的產品發布、技術升級、市場擴張和行銷策略做出明智的決策。
這份全球創傷護理生物製劑市場報告的目標受群眾外包括行業內的各種相關人員，例如投資者、供應商、產品製造商、經銷商、新參與企業和金融分析師。
相關人員可以透過利用創傷護理生物製劑市場分析中使用的各種策略矩陣，更輕鬆地做出決策。

北美洲
- 美國
- 加拿大
拉丁美洲
- 巴西
- 墨西哥
- 阿根廷
- 其他拉丁美洲國家
歐洲
- 德國
- 英國
- 法國
- 義大利
- 西班牙
- 俄羅斯
- 其他歐洲國家
亞太地區
- 中國
- 印度
- 日本
- 澳洲
- 韓國
- ASEAN
- 其他亞太國家
中東
- GCC
- 以色列
- 其他中東國家
非洲
- 南非
- 中非
- 北非

第8章競爭情勢

熱圖分析
市佔率分析（3x3矩陣）
公司簡介
- Smith & Nephew Plc
- Organogenesis, Inc.
- Integra Lifesciences Holdings Corporation
- Skye Biologics
- Alphatec Holdings, Inc.
- Solsys Medical LLC
- Amino Technology LLC
- Osiris Therapeutics, Inc.

第9章

參考
調查方法

簡介目錄

Product Code: CMI1506

Wound Care Biologics Market is estimated to be valued at USD 2.3 Bn in 2026 and is expected to reach USD 3.7 Bn by 2033, growing at a compound annual growth rate (CAGR) of 7.1% from 2026 to 2033.

Report Coverage		Report Details
Base Year:	2025	Market Size in 2026:	USD 2.3 Bn
Historical Data for:	2020 To 2024	Forecast Period:	2026 To 2033
Forecast Period 2026 to 2033 CAGR:	7.10%	2033 Value Projection:	USD 3.7 Bn

Wound care biologic products facilitates in innate repair mechanisms, and involves the use of active biological agents such as animal and plant-derived active biomolecules, which exhibit antioxidant, antimicrobial, or anti-inflammatory properties. Wound care biologic dressings are increasingly being used in post surgeries and severe trauma cases as they provide moist healing environment aiding heat loss, protein and electrolyte loss for faster healing, and prevent bacterial contamination. Biologic skin substitute products include tissue-engineered products, which are designed to either temporarily or permanently replace the altered skin. Skin substitutes are commonly used products for wound management and have application for treating various ailments such as pressure ulcers, diabetic neuropathic ulcers, and vascular insufficiency ulcers.

Market Dynamics

Increasing incidences of chronic ulcers, owing to rising prevalence of diabetes, increasing surgical procedures, and rise in trauma cases are major driving factors for growth of wound care biologics market. According to the survey by World Health Organization, 2014, injuries resulting from traffic collisions, drowning, poisoning, falls or burns account for 9% of the global mortality. Also, according to a study by BMJ Journal Injury Prevention, 2013, an estimated 973 million people sustained injuries that warranted some type of healthcare and 4.8 million people died from injuries. The Journal also stated that major injury causes included road injury (29.1%), self-harm (17.6%), falls (11.6%), and interpersonal violence (8.5%). Manufacturers are also focused on extensive research and development to develop new products and expand their product portfolio. For instance, in 2016, Integra LifeSciences Holdings Corporation received FDA approval for Integra Dermal Regeneration Template (IDRT) for the treatment of diabetic foot ulcers that is marketed under the name of Integra Omnigraft Dermal Regeneration Matrix. Moreover, public awareness for biologics has positively contributed to the market growth, as people are opting for enhanced medical care for preventing wounds to minimize the morbidity associated with the formation of chronic wounds. However, higher cost of the biologics and stringent regulatory approvals for launch of innovative tissue engineered products are hindering growth of the wound care biologics market.

Key features of the study

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrix for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategy adopted by the leading players
It profiles leading players in the global wound care biologics market based on the following parameters - company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, and strategies, and future plans
Key companies covered as a part of this study include Smith & Nephew Plc., Organogenesis, Inc., Integra Lifesciences Holdings Corporation, Skye Biologics, Alphatec Holdings, Inc., Solsys Medical LLC, Amino Technology LLC, and Osiris Therapeutics, Inc.
Insights from this report would allow marketers and the management authorities of the companies to make informed decision regarding their future product launch, technology up-gradation, market expansion, and marketing tactics
The global wound care biologics market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the wound care biologics market

Market Segmentation

By Product Type (Revenue, USD Bn, 2021-2033)
- Skin Substitute
- Biological
- Allografts
- Xenografts
- Others
- Synthetic
- Topical Agents
By Wound Type (Revenue, USD Bn, 2021-2033)
- Chronic Wounds
- Diabetic Foot Ulcers (DFU)
- Venous Leg Ulcers
- Others
- Acute Wounds
- Burns
- Surgical & Traumatic Wounds
- Others
By End User (Revenue, USD Bn, 2021-2033)
- Hospitals
- Clinics
- Ambulatory Surgical Centers
- Home Care Settings
- Others
By Region (Revenue, USD Bn, 2021-2033)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC
- Israel
- Rest of Middle East
- Africa
- South Africa
- Central Africa
- North Africa
Competitive Landscape
- Smith & Nephew Plc.
- Organogenesis, Inc.
- Integra Lifesciences Holdings Corporation
- Skye Biologics
- Alphatec Holdings, Inc.
- Solsys Medical LLC
- Amino Technology LLC
- Osiris Therapeutics, Inc.

1. Research Objective and Assumption

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snippet, By Product Type
- Market Snippet, By Wound Type
- Market Snippet, By End User
- Market Snippet, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Market Opportunities
- Industry Trends
Technological Advancements
Regulatory Scenario
Reimbursement Scenario
Key Highlights
PEST Analysis
Epidemiology
Impact Analysis

4. Global Wound Care Biologics Market, By Product Type, 2021-2033, (US$ Billion)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022-2033
- Segment Trends
Skin Substitute
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Billion)
  - Biological
  - Allografts
  - Xenografts
  - Others
Synthetic
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Billion)
  - Topical Agents

5. Global Wound Care Biologics Market, By Wound Type, 2021-2033, (US$ Billion)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022-2033
- Segment Trends
Chronic Wounds
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Billion)
- Segment Trends
  - Diabetic Foot Ulcers (DFU)
  - Venous Leg Ulcers
  - Others
Acute Wounds
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Billion)
- Segment Trends
  - Burns
  - Surgical & Traumatic Wounds
  - Others

6. Global Wound Care Biologics Market, By End User, 2021-2033, (US$ Billion)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022-2033
- Segment Trends
Hospitals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Billion)
- Segment Trends
Clinics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Billion)
Ambulatory Surgical Centers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Billion)
Home Care Settings
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Billion)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Billion)

7. Global Wound Care Biologics Market, By Region, 2021-2033, (US$ Billion)

Introduction
- Market Share Analysis, By Region, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, For Regions, 2021-2033
North America
- Market Size and Forecast, By Product Type, 2021-2033, (US$ Billion)
- Market Size and Forecast, By Wound Type, 2021-2033, (US$ Billion)
- Market Size and Forecast, By End User, 2021-2033, (US$ Billion)
- Market Size and Forecast, By Country, 2021-2033, (US$ Billion)
  - U.S.
  - Canada
Latin America
- Market Size and Forecast, By Product Type, 2021-2033, (US$ Billion)
- Market Size and Forecast, By Wound Type, 2021-2033, (US$ Billion)
- Market Size and Forecast, By End User, 2021-2033, (US$ Billion)
- Market Size and Forecast, By Country, 2021-2033, (US$ Billion)
  - Brazil
  - Mexico
  - Argentina
  - Rest of Latin America
Europe
- Market Size and Forecast, By Product Type, 2021-2033, (US$ Billion)
- Market Size and Forecast, By Wound Type, 2021-2033, (US$ Billion)
- Market Size and Forecast, By End User, 2021-2033, (US$ Billion)
- Market Size and Forecast, By Country, 2021-2033, (US$ Billion)
  - Germany
  - U.K.
  - France
  - Italy
  - Spain
  - Russia
  - Rest of Europe
Asia Pacific
- Market Size and Forecast, By Product Type, 2021-2033, (US$ Billion)
- Market Size and Forecast, By Wound Type, 2021-2033, (US$ Billion)
- Market Size and Forecast, By End User, 2021-2033, (US$ Billion)
- Market Size and Forecast, By Country, 2021-2033, (US$ Billion)
  - China
  - India
  - Japan
  - Australia
  - South Korea
  - ASEAN
  - Rest of APAC
Middle East
- Market Size and Forecast, By Product Type, 2021-2033, (US$ Billion)
- Market Size and Forecast, By Wound Type, 2021-2033, (US$ Billion)
- Market Size and Forecast, By End User, 2021-2033, (US$ Billion)
- Market Size and Forecast, By Country, 2021-2033, (US$ Billion)
  - GCC
  - Israel
  - Rest of Middle East
Africa
- Market Size and Forecast, By Product Type, 2021-2033, (US$ Billion)
- Market Size and Forecast, By Wound Type, 2021-2033, (US$ Billion)
- Market Size and Forecast, By End User, 2021-2033, (US$ Billion)
- Market Size and Forecast, By Country, 2021-2033, (US$ Billion)
  - South Africa
  - Central Africa
  - North Africa

8. Competitive Landscape

Heat Map Analysis
Market Share Analysis (3x3 Matrix)
Company Profiles
- Smith & Nephew Plc
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Market Strategies
- Organogenesis, Inc.
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Market Strategies
- Integra Lifesciences Holdings Corporation
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Market Strategies
- Skye Biologics
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Market Strategies
- Alphatec Holdings, Inc.
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Market Strategies
- Solsys Medical LLC
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Market Strategies
- Amino Technology LLC
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Market Strategies
- Osiris Therapeutics, Inc.
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Market Strategies
  - Analyst Views